MyCap Mobile Application for Tracking Time Burden of Treatment for Patients With Pancreatic Cancer

NCT07619391 | Recruiting DMC

• 3 other identifiers: OSU-23326NCI-2026-034362020C0221
• Study Type: interventional
• Target: 30
• Locations: 1 country
• Sites: 1

Brief Summary

This clinical trial tests the feasibility of using the MyCap mobile application (app) for tracking time burden from treatment for patients with pancreatic cancer. Pancreatic cancer is best treated with many care teams, such as medical oncology and surgery, requiring patients to dedicate significant time coordinating appointments among different doctors. This time commitment is referred to as time toxicity, defined as the time spent undergoing cancer-related medical care, such as emergency visits, ambulatory care, lab and infusion visits, hospitalizations, and the commuting and waiting times associated with each. At present, time toxicity is still understudied within the medical literature, with no gold standard established for the method of measurement. The MyCap mobile app may be a feasible way to track the time burden from treatment for patients with pancreatic cancer.

Conditions

Pancreatic Adenocarcinoma

Outcome Measures

Primary Outcomes (3)

• Retention rate (feasibility)

  Defined as the number of participants who enroll in the study and complete at least one time log during the study period.

  Up to 8 weeks

• Adherence rate (feasibility)

  Adherence is defined as the percentage of patients who completed over 80% of time logs. Given that this study is evaluating a daily time log over 8 weeks, adherence would require participants to fill out at least 44-time logs.

  Up to 8 weeks

• System usability survey (feasibility)

  Up to 8 weeks

Study Arms (1)

Health Services Research (MyCap app)

EXPERIMENTAL

Patients download the MyCap app onto their phone and fill out a daily time log in the app for 8 weeks.

Other: Electronic Health Record Review; Behavioral: Smartphone Application-based Intervention; Other: Survey Administration

Interventions

Electronic Health Record Review OTHER

Ancillary studies

Health Services Research (MyCap app)

Smartphone Application-based Intervention BEHAVIORAL

Receive access to MyCap application

Also known as: Smartphone App-based Intervention, Smartphone Intervention, Smartphone-based Intervention

Health Services Research (MyCap app)

Survey Administration OTHER

Ancillary studies

Health Services Research (MyCap app)

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Adults ≥ 18 years old
• Diagnosed with pancreatic adenocarcinoma undergoing active treatment or planning to start active treatment within the next 30 days
• English speaking
• Access to a smartphone (Android or iOS)

You may not qualify if:

• Prisoners
• Patients undergoing cancer surveillance

Sponsors & Collaborators

• Ohio State University Comprehensive Cancer Center: lead

Study Sites (1)

Ohio State University Comprehensive Cancer Center

Columbus, Ohio, 43210, United States

RECRUITING

Related Links

• The Jamesline

Study Officials

• Pamela W Lu, MD

  Ohio State University Comprehensive Cancer Center

  PRINCIPAL INVESTIGATOR

Central Study Contacts

The Ohio State University Comprehensive Cancer Center

CONTACT

800-293-5066; OSUCCCClinicaltrials@osumc.edu

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: HEALTH SERVICES RESEARCH
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Principal Investigator

Study Record Dates

• First Submitted: May 26, 2026
• First Posted: June 2, 2026
• Study Start: March 10, 2026
• Primary Completion (Estimated): December 31, 2027
• Study Completion (Estimated): December 31, 2027
• Last Updated: June 2, 2026

Record last verified: 2026-05

Locations

US (1)